Feb 18, 2022
In this episode, Aaron Gerds, MD, discusses his
work on clinical trials and suggestions to improve the process, the
impact of COVID on these trials and his involvement in ASH Clinical
- Welcome to another exciting episode of Oncology Overdrive
- About Gerds :17
- The interview 1:50
- I'd love to hear kind of your journey to becoming a physician
and then really becoming this sub specialized hematologist.
- You work in clinical trials, and really in the infrastructure
of how to implement and make clinical trials most effective for
patients. So how did you get into that? And why do you feel like
that's important? What do you do in that space that you feel is
going to make a difference? 5:22
- Is there a way for us to fix the process of getting a clinical
trial open and completed? 7:01
- Let's say you were king for a day, and you were able to disrupt
the entire system and fix it. What would you do?
- How has COVID impacted what you've been doing in clinical
trials and infrastructure? What are the things that have really
been challenges? 16:08
- So how did you get involved in ASH Clinical News? What exactly
is your role? And why do you think something like ASH clinical news
is important? 25:58
- If somebody is interested in becoming that voice of getting
accurate information out there, whether it's through ASH or through
another forum, what do you suggest for them? What's the best way to
get engaged and involved in that space?
- If somebody could only listen to the last minute of this
conversation, what would you want them to take away? What are the
key takeaways from today's conversation that you would want someone
to remember? 34:33
- How to contact Dr. Gerds 36:05
- Thanks for listening 37:08
Aaron Gerds, MD, is assistant professor in
medicine, specializing in hematology and medical oncology, at the
Cleveland Clinic Taussig Cancer Institute and editor-in-chief of
American Society of Hematology Clinical News.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at email@example.com.
Follow us on Twitter @HemOncToday and @ShikhaJainMD. Gerds can be reached on
Disclosures: Gerds reports no relevant
financial disclosures. Jain reports she is a paid freelance writer